key: cord-0944469-4c28hdle
authors: Sanjay, Srinivasan; Kawali, Ankush; Mahendradas, Padmamalini
title: Acute macular neuroretinopathy and COVID-19 vaccination
date: 2022-01-03
journal: Indian J Ophthalmol
DOI: 10.4103/ijo.ijo_2542_21
sha: a0160b6e645d0b27b262822c310746ae11cd5907
doc_id: 944469
cord_uid: 4c28hdle

nan

Dear Editor, We read with interest the article by Vinzamuri et al. [1] The hyperreflective lesions seen on ganglion layer could represent sections across the vessels. It would be helpful if the optical coherence tomography images would be accompanied by section through which it was taken. Since acute macular neuroretinopathy (AMN) and paracentral middle maculopathy (PAMM) are possibly related to vascular occlusion either a fundus fluorescein angiography or optical coherence tomography angiography can add value to their case. In AMN, changes occur due to reduced retinal perfusion at the level of deep capillary plexus, which provides retinal perfusion to the zone between the retinal and choroidal circulations. [2, 3] AMN multimodal imaging findings described could be dark lesions on red-free imaging, hypo-autofluorescence on fundus autofluorescence, and early and late hypofluorescence on fluorescein angiography. Infrared imaging also detected the lesions with a darkened outline. [4] Despite complete visual recovery, there is a possibility of persisting scotoma which may be as a result of thinning of the affected retinal layers. [5] We agree with the authors that AMN and PAMM following COVID-19 vaccine may not be causal and may have to be explored further.

Dear Editor, We read with interest the article by Ish et al. [1] about a 50-year-old male who developed right-sided facial palsy three weeks after having received the second dose of the Indian Covaxin® vaccine. A causal relationship between vaccination and palsy was assumed. [1] Partial recovery was achieved after 10 days of glucocorticoids. [1] The study is appealing but raises the following comments and concerns.

Peripheral facial palsy has been repeatedly reported as a complication of SARS-CoV-2 vaccinations. [2] In the majority of cases, facial palsy is of the peripheral type. Facial palsy may occur as an isolated condition or together with lesions of other cranial nerves or even together with affection of peripheral nerves. In the latter case, Guillain-Barre syndrome (GBS) with affection of cranial nerves is diagnosed. [3] Thus, we should know if the patient was seen by a neurologist and if affection of other cranial or peripheral nerves was appropriately excluded. Fig. 1 does not show the front of the patient's face; thus, it cannot be assessed if facial palsy was of the central or peripheral type. There is also no mention in the text about which of these two types was found in the patient. Differentiating between the two is crucial as treatment and outcome may vary significantly. We should be told if a cerebral MRI had been carried out and if it was normal or indicative of Bickerstaff encephalitis (BBE).

After 10 days of steroid treatment, only incomplete recovery was achieved. We should know why no immunoglobulins were given and the long-term outcome and if recovery could be confirmed by nerve conduction studies of the right facial nerve.

Overall, the elegant study has limitations that challenge the results and their interpretation. We should know if facial palsy was of the central or peripheral type and whether GBS was present or not.

Informed consent was obtained.

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Nil.

There are no conflicts of interest.

The study was approved by the institutional review board.

Comment on: Central retinal vein occlusion secondary to varicella zoster retinal vasculitis in an immunocompetent individual during the COVID-19 pandemic -A case report

Aqueous humor polymerase chain reaction in uveitis-utility and safety

The treatment of hyperhomocysteinemia

Bilateral paracentral acute middle maculopathy and acute macular neuroretinopathy following COVID-19 vaccination

Optical coherence tomography angiography: Potential artifacts in acute macular neuroretinopathy

Retinal microvasculature alteration in paracentral acute middle maculopathy and acute macular neuroretinopathy: A quantitative optical coherence tomography angiography study

Facial nerve palsy after COVID-19 vaccination -A rare association or a coincidence

Bell's palsy after 24 hours of mRNA-1273 SARS-CoV-2 vaccine

Exacerbating Guillain-Barré syndrome eight days after vector-based COVID-19 vaccination